Related Experiment Video
Updated: May 22, 2026

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension
Published on: June 27, 2025
Prevalence and predictors of left ventricular hypertrophy in patients with hypertension and normal electrocardiogram
Emilio Nardi1, Alessandro Palermo, Giuseppe Mulè
1Dipartimento di Medicina Interna e Specialistica (DIMIS), Excellence Centre of the European Society of Hypertension, Università degli Studi di Palermo, Italy.
Insights
Left ventricular hypertrophy (LVH) is uncommon in hypertensive patients with normal electrocardiograms (ECG) and no other diseases. Longer hypertension duration predicts LVH, suggesting targeted echocardiography for these patients.
Area of Science:
- Cardiology
- Hypertension Research
- Diagnostic Imaging
Background:
- Electrocardiography (ECG) exhibits limited sensitivity for detecting left ventricular hypertrophy (LVH).
- Echocardiography, while effective, is not routinely performed for LVH screening.
Purpose of the Study:
- To determine the prevalence of LVH and diastolic dysfunction in hypertensive patients with normal ECG.
- To identify predictors of LVH in this specific patient cohort.
Main Methods:
- 440 hypertensive patients without cardiovascular disease, diabetes, or kidney disease were enrolled.
- Echocardiography was used to assess LV mass indexed by body surface area (LVMI) and diastolic function.
- LVH was defined as LVMI >125 g/m² (men) or >110 g/m² (women).
Main Results:
- The prevalence of LVH was 8.18% in patients with normal ECG.
- Hypertension duration was the sole independent predictor of LVH (p < 0.001), with an AUC of 0.878.
- Diastolic dysfunction was detected in only 3.2% of patients.
Conclusions:
- LVH prevalence is low in hypertensive patients without comorbidities and normal ECG.
- Patients with echocardiographic LVH had mild elevations in LVMI.
- Echocardiography may be best reserved for hypertensive patients with longer disease duration.
Background:
Electrocardiography (ECG) has low sensitivity for detecting left ventricular hypertrophy (LVH), while echocardiography cannot be routinely performed.
Design/Methods:
In this study we evaluate the prevalence of LVH and diastolic dysfunction in hypertensive patients with normal ECG. We excluded patients with cardiovascular (CV) diseases, diabetes, chronic kidney disease, or presenting ECG-LVH or other ECG anomalies. The enrolled 440 hypertensive patients underwent echocardiographic examination (Acuson Sequoia 512); LV mass was indexed by body surface area (LVMI) and LVH was defined as LVMI >125 g/m(2) in men and >110 g/m(2) in women. Diastolic function was evaluated by mitral inflow and tissue Doppler imaging (TDI).
Results:
The prevalence of LVH was 8.18% (95% confidence interval [CI] 5.97-11.1%). Multiple regression analysis showed that the only variable independently associated with LVH was duration of hypertension (p < 0.001). The receiver operating characteristic (ROC) curve showed that duration of hypertension was a powerful predictor of LVH, with an area under the curve (AUC) of 0.878 and p < 0.0001. Further, in patients with LVH the mean difference of LVMI from the cut-off value for LVH was 12.3 ± 9.19 g/m(2). Diastolic dysfunction, defined as early diastolic myocardial velocity (Em) <0.08 m/s, was detected only in 3.2% of patients.
Conclusions:
The prevalence of LVH among hypertensive patients with normal ECG, free of diabetes and of CV diseases is low; moreover, patients with echocardiographic LVH presented LVMI values that identified mild LVH. Few cases of impaired diastolic function were registered. We suggest that in hypertensive patients with such characteristics the echocardiographic examination should be reserved to those who present with higher duration of hypertension.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertension III: Clinical Manifestations and Diagnostic Studies
Heart Failure II: Pathophysiology
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Pathophysiology of Heart Failure
Mitral Regurgitation I: Introduction
